General MedicationsINTRAPERITONEALGeneric

INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Standard Dose

18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 020374 (ANDA).

Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength SOLUTION;INTRAPERITONEAL - 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML Sponsor FRESENIUS Submission history Latest submission status date: 2002-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 020374 (ANDA). Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength SOLUTION;INTRAPERITONEAL - 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML Sponsor FRESENIUS Submission history Latest submission status date: 2002-01-22 00:00:00. Submission type: SUPPL.

Monitoring

• Review priority: STANDARD
• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.